michael mark, md
Kantonsspital Graubünden
2
1
1
N/A
0
0
Research Impact
N/A
Research impact score
0
Total publications
0
Published trial results
0
Total citations
Drug Portfolio
Analytics
Trial Phases
Trial Status
Role Distribution
Activity Timeline
Clinical Trials (2)
Research Network
Collaboration Network
Research Areas & Affiliations
Therapeutic Areas
Affiliations
Similar Key Opinion Leaders
Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.
Mariano Provencio, MD
Fundación GECP President
Shared therapeutic areas:
María J Méndez, MD
COMPLEJO HOSPITALARIO REGIONAL REINA SOFÍA, Servicio de Oncología Médica
Shared therapeutic areas:
Daniel Kwon, MD
University of California, San Francisco
Shared therapeutic areas:
Zhengfei Zhu, MD
Fudan University
Shared therapeutic areas:
Neeta Pandit-Taskar, MD
Memorial Sloan Kettering Cancer Center
Shared therapeutic areas:
Stanislaw R. Burzynski, MD, PhD
Burzynski Research Institute
Shared therapeutic areas:
Francesco Perrone, M.D., Ph.D
National Cancer Institute Naples, Italy; Director Clinical Trials Unit
Shared therapeutic areas:
Pablo Maroto, MD
HOSPITAL DE LA SANTA CREU I SANT PAU, Servicio de Oncología Médica
Shared therapeutic areas:
William D Figg, Pharm.D.
National Cancer Institute (NCI)
Shared therapeutic areas:
Begoña Perez-Valderrama, MD
COMPLEJO HOSPITALARIO REGIONAL VIRGEN DEL ROCIO, Servicio de Oncología Médica
Shared therapeutic areas:
Publications (0)
No publications found for this investigator.
Clinical Trials (2)
Showing 2 of 2 trials
1st Line Durvalumab in PS 2 NSCLC Patients
Impact of the Addition of Metformin to Abiraterone in Metastatic Prostate Cancer Patients
All 2 trials loaded